EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Structural Evaluation of a Nitroreductase Engineered for Improved Activation of the 5-Nitroimidazole PET Probe SN33623

Abigail V Sharrock iD, Jeff S Mumm, Elsie M Williams, Narimantas Čėnas, Jeff B Smaill iD, Adam V Patterson iD, David F Ackerley iD, Gintautas Bagdžiūnas iD, Vickery L Arcus

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms25126593 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Abigail V Sharrock und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Biological Sciences, Victoria University of Wellington, Wellington 6012, New Zealand. Hauptthemen laut MEDLINE: Nitroreductases, Nitroimidazoles, Metronidazole. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIMH NIH HHS, NIH HHS, Royal Society Te Apārangi.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bacterial nitroreductase enzymes capable of activating imaging probes and prodrugs are valuable tools for gene-directed enzyme prodrug therapies and targeted cell ablation models. We recently engineered a nitroreductase (E. coli NfsB F70A/F108Y) for the substantially enhanced reduction of the 5-nitroimidazole PET-capable probe, SN33623, which permits the theranostic imaging of vectors labeled with oxygen-insensitive bacterial nitroreductases. This mutant enzyme also shows improved activation of the DNA-alkylation prodrugs CB1954 and metronidazole. To elucidate the mechanism behind these enhancements, we resolved the crystal structure of the mutant enzyme to 1.98 Å and compared it to the wild-type enzyme. Structural analysis revealed an expanded substrate access channel and new hydrogen bonding interactions. Additionally, computational modeling of SN33623, CB1954, and metronidazole binding in the active sites of both the mutant and wild-type enzymes revealed key differences in substrate orientations and interactions, with improvements in activity being mirrored by reduced distances between the N5-H of isoalloxazine and the substrate nitro group oxygen in the mutant models. These findings deepen our understanding of nitroreductase substrate specificity and catalytic mechanisms and have potential implications for developing more effective theranostic imaging strategies in cancer treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NitroreductasesNitroimidazolesMetronidazoleProdrugsEscherichia coli ProteinsPositron-Emission TomographyEscherichia coliCatalytic DomainProtein EngineeringModels, MolecularAziridines

Stichwörter der Autor:innen

CB1954NfsBSN33623cancer gene therapycrystal structuremetronidazoleprodrugtargeted cellular ablationtheranostic imagingtype I nitroreductase

Substanzen

NitroreductasesNitroimidazolesMetronidazoleProdrugs4-nitroimidazoleEscherichia coli ProteinstretazicarNfsB protein, E coliAziridines

Autor:innen und Institutionen

  • School of Biological Sciences, Victoria University of Wellington, Wellington 6012, New Zealand.
  • Wilmer Eye Institute, Johns Hopkins University, Baltimore, MD 21287, USA.
  • Institute of Biochemistry, Life Sciences Center at Vilnius University, Saulėtekio Av. 7, LT-10257 Vilnius, Lithuania.
  • Auckland Cancer Society Research Centre, School of Medical Sciences, The University of Auckland, Auckland 1142, New Zealand.
  • Te Aka Mātuatua School of Science, University of Waikato, Hamilton 3240, New Zealand.

ORCID-Profile: Abigail V Sharrock, Jeff B Smaill, Adam V Patterson, David F Ackerley, Gintautas Bagdžiūnas

Förderung

  • NIMH NIH HHS
  • NIH HHS
  • Royal Society Te Apārangi
  • the US National Institutes of Health
  • the Royal Society of New Zealand Marsden Fund
  • Royal Society of New Zealand Marsden Fund
  • US National Institutes of Health
  • Health Research Council of New Zealand

Zitieren

APA

Sharrock, A. V., Mumm, J. S., Williams, E. M., Čėnas, N., Smaill, J. B., Patterson, A. V., Ackerley, D. F., Bagdžiūnas, G., & Arcus, V. L. (2024). Structural Evaluation of a Nitroreductase Engineered for Improved Activation of the 5-Nitroimidazole PET Probe SN33623. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25126593

Vancouver

Sharrock AV, Mumm JS, Williams EM, Čėnas N, Smaill JB, Patterson AV, et al. Structural Evaluation of a Nitroreductase Engineered for Improved Activation of the 5-Nitroimidazole PET Probe SN33623. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25126593

BibTeX
@article{Sharrock2024,
  author = {Sharrock, Abigail V and Mumm, Jeff S and Williams, Elsie M and Čėnas, Narimantas and Smaill, Jeff B and Patterson, Adam V and Ackerley, David F and Bagdžiūnas, Gintautas and Arcus, Vickery L},
  title = {Structural Evaluation of a Nitroreductase Engineered for Improved Activation of the 5-Nitroimidazole PET Probe SN33623},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms25126593}
}
Kostenlos starten →